Levin Capital Strategies L.P. purchased a new position in Prime Medicine, Inc. (NYSE:PRME – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 20,000 shares of the company’s stock, valued at approximately $177,000. Other hedge funds have also recently modified their holdings of […]
Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday . The company traded as low as $4.32 and last traded at $4.50, with a volume of 130514 shares traded. The stock had previously closed at $4.70. Wall Street Analyst Weigh In PRME has been the […]
Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $6.18, but opened at $5.82. Prime Medicine shares last traded at $5.84, with a volume of 56,931 shares trading hands. Analyst Ratings Changes A number of analysts recently weighed in […]
Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $6.87, but opened at $7.10. Prime Medicine shares last traded at $6.70, with a volume of 113,845 shares changing hands. Analyst Ratings Changes Several equities research analysts have recently issued […]
Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s share price gapped up prior to trading on Wednesday following insider buying activity. The stock had previously closed at $8.03, but opened at $8.59. Prime Medicine shares last traded at $8.34, with a volume of 55,245 shares changing hands. Specifically, Director Robert Nelsen bought 3,200,000 shares of […]